NIH to Scientists: Get Grant Requests in Soon

Courtesy of CDC/Larry Stauffer HIGH-PRIORITY KILLERS: NIH welcomes proposals to study vaccines and treatments for these and other pathogens. Memo to life scientists who want to take advantage of new research funding for bioterrorism and biodefense: Submit your federal grant applications now, even though the US government's fiscal year 2003 budget is still up in the air. "Investigators should not hesitate to put in applications for grants or respond to RFPs [Request for Proposals] and con

Written byTed Agres
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Memo to life scientists who want to take advantage of new research funding for bioterrorism and biodefense: Submit your federal grant applications now, even though the US government's fiscal year 2003 budget is still up in the air. "Investigators should not hesitate to put in applications for grants or respond to RFPs [Request for Proposals] and contracts," says Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID). "You'd be making a big mistake because you may miss a grant or contract cycle if you [hesitate]. The president and the Congress both want a budget--and it will happen."

The question, of course, is how much and when. No one knows what the National Institutes of Health's final budget will be or when it will be approved. Assuming action on the budget happens soon after Congress convenes this month, NIAID intends to fund more than $1.7 billion ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series